详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Ning Li[1] * ; Youzhong Zhang[2] ; Jing Wang[3] ; Jianqing Zhu[4] ; Li Wang[5] ; Xiaohua Wu[6] ; Desheng Yao[7] ; Qiang Wu[8] ; Jihong Liu[9] ; Junying Tang[10] ; Rutie Yin[11] ; Guonan Zhang[12]

; Ge Lou[13] ; Ruifang An[14] ; Xiaoping Xia[15] ; Qingshui Li[16] ; Yaping Zhu[17] ; Zheng Hong[18] ; Xinfeng Yang[19] ; Yuanjing Hu[20] ; Xin Zhang[21] ; Xiaoyun Wan[22] ; Jing Qu[23] ; Ben Zhang[23] ; Lingying Wu[1] ;

机构： [1]National Cancer Center/Cancer Hospital, Chinese Academy of MedicalSciences and Peking Union Medical College, Beijing, China, [2]QiluHospital of Shandong University, Shandong, China, [3]The AffiliatedCancer Hospital of Xiangya School of Medicine, Central South University,Changsha, China, [4]Cancer Hospital of the University of Chinese Academyof Sciences (Zhejiang Cancer Hospital), Beijing, China, [5]Affiliated CancerHospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou,Henan, China, [6]Fudan University Affiliated Cancer Hospital, Shanghai,China, [7]Guangxi Medical University Affiliated Tumor Hospital, Nanning,Guangxi, China, [8]Jiangsu Cancer Hospital, NanJing, JiangSu, China, [9]Sun Yat-Sen University Cancer Center, Guangzhou, China, [10]The FirstAffiliated Hospital of Chongqing Medical University, Chongqing, China, [11]West China Second University Hospital, Sichuan University, Chengdu,Sichuan, China, [12]Sichuan Cancer Hospital, Chengdu, China, [13]HarbinMedical University Cancer Hospital, Harbin, China, [14]The First AffiliatedHospital of Xi’an Jiaotong University, Xi’an, China, [15]Anhui Provincial Cancer Hospital, Anhui, China, [16]Shandong Cancer Hospital and Institute,Shandong, China, [17]Shanghai General Hospital, Shanghai, China, [18]BeijingCancer Hospital, Beijing, China, [19]Jiangxi Cancer Hospital, Jiangxi, China, [20]Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China, [21]Liaoning Cancer Hospital & Insititute, Liaoning, China, [22]Woman’sHospital, School of Medicine, Zhejiang University, Hangzhou, China, [23]Jiangsu Hengrui Medicine Co. Ltd, Shanghai, China

出处：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 2 区

医学

小类 | 2 区肿瘤学 2 区妇产科学

最新[2023]版：

大类 | 2 区

医学

小类 | 1 区妇产科学 2 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 OBSTETRICS & GYNECOLOGY Q2 ONCOLOGY

最新[2023]版：

Q1 OBSTETRICS & GYNECOLOGY Q1 ONCOLOGY

第一作者：

第一作者机构： [1]National Cancer Center/Cancer Hospital, Chinese Academy of MedicalSciences and Peking Union Medical College, Beijing, China,

推荐引用方式(GB/T 7714)：

APA：

MLA：

Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial

文献详情